RC
FLGT icon

Regents Capital’s Fulgent Genetics FLGT Stock Holding History

Regents Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1.11M Buy
+12,000
New +$958K 1.44% 7

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Regents Capital's FLGT Position: Q2 2021 in Review

Regents Capital opened a new position in Fulgent Genetics (FLGT) in Q2 2021: 12,000 shares worth $1.11M. The stake represents 1.44% of the portfolio and ranks #7 among its holdings.

254 funds tracked by Wall St. Rank hold FLGT as of Q2 2021.

  • Regents Capital held 12,000 shares of Fulgent Genetics worth $1.11M as of Q2 2021.
  • Fulgent Genetics was a new Regents Capital position in Q2 2021.
  • Fulgent Genetics made up 1.44% of Regents Capital's portfolio in Q2 2021, its #7 holding.
  • 254 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2021.

Based on Regents Capital's 13F filing for Q2 2021, filed 16 Aug 2021.